Rate Video

iwMyeloma 2015 | Clinical utility of flow cytometry in multiple myeloma

Bruno Paiva • 11 Apr 2015

Multiple Myeloma

At the Myeloma 2015 meeting, Dr Bruno Paiva (University of Navarra, Spain) discusses the utility of flow cytometry as a therapeutic tool to identify precursor cells and detect the presence or absence of minimal residue disease (MRD) in multiple myeloma.

Speaker: Bruno Paiva

Using validated next-generation techniques for monitoring MRD in multiple myeloma

Predicting MRD outcomes in myeloma using machine learning

Bruno Paiva • 30 Nov 2021

The assets of MRD in myeloma

Bruno Paiva • 23 Sep 2020

Impressive detection with NGF MRD

Bruno Paiva • 15 May 2020

Related Videos

PHE885, a novel BCMA-directed CAR-T therapy for patients with R/R multiple myeloma

Adam Sperling • 13 Jun 2022

Dual-targeting BCMA/CD19 CAR-T therapy in patients with R/R MM

Juan Du • 13 Jun 2022

The association between prior exposure to lenalidomide and TP53-mutated AML/MDS

Adam Sperling • 13 Jun 2022

Updates in immunotherapy for multiple myeloma: BiTEs & novel targets

Adam Sperling • 13 Jun 2022